Contribution: Industrial Research Assistance Program – Contributions to Firms
StressMarq Biosciences Inc.
$227,000.00
Development of oligomeric forms of prion-like proteins.
EF 2020-21 · 2020-05-01
Résumé
This project will develop techniques to generate active, soluble oligomeric constructs of prion-like proteins relevant in neurological disease, including Tau, alpha synuclein and Abeta, using a variety of physical and chemical techniques.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Victoria|Victoria, British Columbia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
838513760
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Modifications
Chaque version de l'entente telle que publiée, de la plus ancienne à la plus récente, avec son total à cette version. Le montant ci-dessus est le plus récent.
| Modification | Date | Exercice financier | Total |
|---|---|---|---|
| 0 | 2020-05-01 | 2020-21 | $190,000.00 |
| 1 | 2020-05-01 | 2020-21 | $227,000.00 |
Tel que publié
Additional Information
This agreement has been amended 1 time(s). The total amended value is 37,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 37 000 dollars.
Agreement End Date
2021-10-29
Agreement Number
948559
Agreement Start Date
2020-05-01
Agreement Title
Development of oligomeric forms of prion-like proteins.
Agreement Title (French)
Mise au point de substances oligomériques de protéines de type prion
Agreement Type
Contribution
Agreement Value
$227,000.00
Amendment Date
2020-12-03
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will develop techniques to generate active, soluble oligomeric constructs of prion-like proteins relevant in neurological disease, including Tau, alpha synuclein and Abeta, using a variety of physical and chemical techniques.
Description (French)
Ce projet permettra de mettre au point des techniques pour générer des substances oligomériques actives et solubles de protéines de type prion pertinentes dans les maladies neurologiques, notamment la protéine tau, la protéine alpha-synucléine et la protéine bêta-amyloïde, en utilisant diverses techniques physiques et chimiques.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Victoria
Federal Riding (French)
Victoria
Federal Riding Number
59041
NAICS Code
32519
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
838513760
Recipient City
Victoria|Victoria
Recipient Country
CA
Recipient Legal Name
StressMarq Biosciences Inc.
Recipient Postal Code
V8T 2C1
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2020-2021-Q1-948559
